carbapenems has been researched along with cephalothin in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (cephalothin) | Trials (cephalothin) | Recent Studies (post-2010) (cephalothin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 2,621 | 196 | 94 |
| Protein | Taxonomy | carbapenems (IC50) | cephalothin (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 1 isoform b | Homo sapiens (human) | 7.28 | |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 2.786 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babic, M; Bethel, CR; Bonomo, RA; Caselli, E; Distler, AM; Drawz, SM; Ori, C; Prati, F; Taracila, M | 1 |
1 other study(ies) available for carbapenems and cephalothin
| Article | Year |
|---|---|
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
Topics: Acinetobacter; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalothin; Drug Design; Escherichia coli; Gram-Negative Bacteria; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Penicillinase; Protein Conformation; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2010 |